Search

Lauren C Costantini

Deceased

from Boulder, CO

Also known as:
  • Lauren Catherine Costantini
  • Lauren Costantini
  • Lauren Constantini

Lauren Costantini Phones & Addresses

  • Boulder, CO
  • 459 33Rd Ave, San Francisco, CA 94121
  • 29 Coolidge Ave, Allston, MA 02134 • 617-7822789
  • Boston, MA
  • San Bruno, CA
  • Albany, NY

Work

  • Company:
    RE/MAX OF BOULDER INC
  • Address:
    Boulder, CO
  • Phones:
    303-4497000

Images

Resumes

  • Lauren Costantini Photo 1

    Lauren C. Costantini, Ph.d.

    view source
  • Position:
    Vice President of Medical and Clinical Affairs (consultant) at Clarimedix Inc., Principal Consultant at LCC Consulting, LLC., Advisor at Fitzsimons BioBusiness Partners and Boulder Innovation Center, Technical & Business Advisory Committee at CO Institute for Drug, Device & Diagnostic Development, Instructor at Regional Training Center for Product Translation, Instructor at Rocky Mountain Innovation Initiative, RMI2
  • Location:
    Greater Denver Area
  • Industry:
    Biotechnology
  • Work:
    Clarimedix Inc. since Aug 2009
    Vice President of Medical and Clinical Affairs (consultant)

    LCC Consulting, LLC. since Jul 2009
    Principal Consultant

    Fitzsimons BioBusiness Partners and Boulder Innovation Center since 2008
    Advisor

    CO Institute for Drug, Device & Diagnostic Development since Jan 2008
    Technical & Business Advisory Committee

    Regional Training Center for Product Translation since Oct 2007
    Instructor
  • Education:
    Harvard Medical School 1996 - 1997
    Post-Doctoral, Neuroregeneration
    Albany Medical College 1992 - 1996
    PhD, Neuroscience/Biomedical Science
    Purchase College 1988 - 1992
    BS, Biology/Chemistry with Dance minor
  • Skills:
    Strategic planning
    creation of Business Plans
    Design and execution of R&D
    pre-clinical
    clinical phase I-III
    Regulatory pre-IND through launch
    FDA and ex-US regulatory meetings
    labeling
    Medical Foods
    Licensing and patent evaluations
    due diligence
    partnership discussions
    funding opportunities
    Marketing
    commercialization
    post-market regulatory compliance
    Teaching product translation courses through a variety of university and conference-based organizations
  • Lauren Costantini Photo 2

    Co-Founder At Lokalite

    view source
  • Position:
    Co-Founder at Lokalite
  • Location:
    Boulder, Colorado
  • Industry:
    Events Services
  • Work:
    Lokalite - Boulder, CO since Apr 2010
    Co-Founder
  • Education:
    University of Colorado at Boulder - Leeds School of Business 2006 - 2010
  • Interests:
    Skiing, Jigsaw Puzzles, Hiking, Baking, Learning New Things, Visiting New Places, and Being an Entrepreneur!
  • Lauren Costantini Photo 3

    Vice President, R&Amp;D At Sierra Neuro

    view source
  • Position:
    Vice President, R&D at Sierra Neuro
  • Location:
    Greater Denver Area
  • Industry:
    Biotechnology
  • Work:
    Sierra Neuro
    Vice President, R&D

Us Patents

  • Implantable Polymeric Device For Sustained Release Of Dopamine Agonist

    view source
  • US Patent:
    20080311171, Dec 18, 2008
  • Filed:
    May 12, 2008
  • Appl. No.:
    12/119334
  • Inventors:
    Rajesh A. PATEL - Redwood City CA,
    Louis R. Bucalo - Miami Beach FL,
    Lauren Costantini - San Francisco CA,
    Sofie Kleppner - Burlingame CA,
  • International Classification:
    A61K 9/00
    A61K 31/435
    A61K 31/437
    A61K 31/56
    A61P 29/00
    A61P 25/16
  • US Classification:
    424423, 514284, 514288, 514169
  • Abstract:
    The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
  • Implantable Polymeric Device For Sustained Release Of Dopamine Agonist

    view source
  • US Patent:
    20090162412, Jun 25, 2009
  • Filed:
    Dec 22, 2008
  • Appl. No.:
    12/341766
  • Inventors:
    Rajesh A. Patel - Redwood City CA,
    Louis R. Bucalo - Miami FL,
    Lauren Costantini - San Francisco CA,
    Sofie Kleppner - Palo Alto CA,
  • International Classification:
    A61K 9/00
    A61P 25/00
  • US Classification:
    424422
  • Abstract:
    The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
  • Implantable Polymeric Device For Sustained Release Of Dopamine Agonist

    view source
  • US Patent:
    20120258161, Oct 11, 2012
  • Filed:
    Jun 15, 2012
  • Appl. No.:
    13/525193
  • Inventors:
    Rajesh A. PATEL - Redwood City CA,
    Louis R. Bucalo - Miami FL,
    Lauren Costantini - San Francisco CA,
    Sofie Kleppner - Palo Alto CA,
  • International Classification:
    A61K 9/00
    A61K 31/473
    A61P 25/14
    A61P 29/00
    A61P 15/00
    A61K 31/56
    A61P 25/16
  • US Classification:
    424423, 514171, 514284
  • Abstract:
    The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
  • Implantable Polymeric Device For Sustained Release Of Nalmefene

    view source
  • US Patent:
    20050031668, Feb 10, 2005
  • Filed:
    May 27, 2004
  • Appl. No.:
    10/856178
  • Inventors:
    Rajesh Patel - Redwood City CA,
    Louis Bucalo - San Francisco CA,
    Lauren Costantini - San Francisco CA,
  • International Classification:
    A61K031/485
  • US Classification:
    424426000, 514282000
  • Abstract:
    The present invention provides compositions, methods, and kits for administration of nalmefene for treatment of alcoholism, nicotine dependence, or another condition for which treatment with nalmefene is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases nalmefene continuously with generally linear release kinetics for extended periods of time. Nalmefene is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with nalmefene.
  • Implantable Polymeric Device For Sustained Release Of Dopamine Agonist

    view source
  • US Patent:
    20050031667, Feb 10, 2005
  • Filed:
    Mar 31, 2004
  • Appl. No.:
    10/815481
  • Inventors:
    Rajesh Patel - Redwood City CA,
    Louis Bucalo - Miami Beach FL,
    Lauren Costantini - San Francisco CA,
    Sofie Kleppner - Burlingame CA,
  • International Classification:
    A61F002/00
  • US Classification:
    424426000, 514295000
  • Abstract:
    The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.

Real Estate Brokers

  • Lauren Costantini Photo 4

    Lauren Costantini, Boulder CO Agent

    view source
  • Work:
    RE/MAX OF BOULDER INC
    Boulder, CO
    303-4497000 (Phone)

Googleplus

  • Lauren Costantini Photo 5

    Lauren Costantini

    • Links:
      Picasa Web Albums
  • Lauren Costantini

    Lauren Costantini Photo 6

Facebook

  • Lauren Costantini

  • Lauren Costantini

  • Lauren Costantini


Get Report for Lauren C Costantini from Boulder, CODeceased
Control profile